High materiality9/10
Immunic initiated with an Outperform at Wedbush
Why it may matterVerify against the original reporting
Outperform
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wedbush initiates Immunic with an Outperform rating and price target of $45; current price $16.06.
- Outperform rating from Wedbush
- Target $45 vs $16.06 price
Key facts
- 01
Target: $45
- 02
Posted price: $16.06
- 03
Analyst firm: Wedbush
- 04
Analyst: Martin Fan
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.